{"gene":"KCNJ11","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":1997,"finding":"Truncation of Kir6.2 (removing the last 26 C-terminal residues) allows it to form functional ATP-sensitive K+ channels in the absence of SUR1, demonstrating that the primary ATP inhibitory site resides on Kir6.2, while SUR1 is required for sensitivity to sulphonylureas, diazoxide, and activation by Mg-ADP.","method":"Heterologous expression of truncated Kir6.2 (Kir6.2ΔC26) in Xenopus oocytes; electrophysiology","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in heterologous system with mutagenesis, foundational study replicated widely","pmids":["9144288"],"is_preprint":false},{"year":1997,"finding":"Asparagine 160 (N160) in Kir6.2 lines the pore and contributes to inward rectification by interacting with Mg2+ and spermine; mutation of N160 also alters ATP sensitivity indirectly by changing the open probability of the channel (the energy of the open state), rather than directly affecting ATP binding.","method":"Site-directed mutagenesis of N160 in Kir6.2/SUR1 channels expressed in COSm6 cells; electrophysiology","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with quantitative channel kinetics and current-voltage analysis","pmids":["9236207"],"is_preprint":false},{"year":1999,"finding":"PKA phosphorylates Kir6.2 at Ser372 in the C-terminus in intact cells following Gs-coupled receptor stimulation, and this phosphorylation increases K(ATP) channel activity; phosphorylation of SUR1 at Ser1571 by PKA modulates basal channel properties by decreasing burst duration and interburst interval and increasing surface channel number.","method":"Mutagenesis of PKA consensus sites in SUR1 and Kir6.2; phosphorylation assays in Xenopus oocyte homogenates and intact cells; electrophysiology","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with phosphorylation assays and functional electrophysiology","pmids":["10469651"],"is_preprint":false},{"year":1999,"finding":"The N-terminus of Kir6.2 is involved in coupling sulphonylurea binding to SUR1 to closure of the Kir6.2 pore; deletion of 14 N-terminal amino acids (ΔN14) raises open probability, reduces ATP sensitivity, and abolishes high-affinity tolbutamide block when co-expressed with SUR1, without altering intrinsic Kir6.2 properties when expressed alone.","method":"N-terminal deletion and site-directed mutagenesis of Kir6.2; macroscopic current recording in excised patches from Xenopus oocytes","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — systematic deletion mutagenesis with functional electrophysiology","pmids":["10381582"],"is_preprint":false},{"year":1999,"finding":"Arginine 50 (R50) in the N-terminus of Kir6.2 is required for normal ATP inhibition; mutation R50S reduces ATP sensitivity ~7-fold; combining N-terminal (R50S) and C-terminal (E179Q) mutations synergistically increases ATP insensitivity, indicating both termini cooperate in ATP-inhibitory gating.","method":"Site-directed mutagenesis at R50 and other N-terminal residues of Kir6.2ΔC26; electrophysiology in Xenopus oocytes","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with functional readout, synergy experiment","pmids":["9831713"],"is_preprint":false},{"year":1999,"finding":"N-terminal truncations of Kir6.2 nearly eliminate transitions to interburst closed states, producing extremely high open probability; this reduces apparent ATP sensitivity consistent with the N-terminus controlling interburst gating through a closed state that preferentially binds inhibitory ATP.","method":"N-terminal truncation constructs of Kir6.2/SUR1; patch-clamp electrophysiology in heterologous cells","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with kinetic analysis of channel gating","pmids":["10049691"],"is_preprint":false},{"year":1999,"finding":"Kir6.2 physically associates with SUR2A to form the cardiac K(ATP) channel; the proximal C-terminus and M2 transmembrane domain of Kir6.2 are required for this subunit association, while the distal C-terminal 37 amino acids are dispensable.","method":"Co-immunoprecipitation of in vitro-translated Kir6.2 and SUR2A; C-terminal deletion mutants","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal co-IP with deletion mapping in vitro","pmids":["10093054"],"is_preprint":false},{"year":1997,"finding":"Kir6.2 protein is localized to the plasma membrane of pancreatic islet alpha-, beta-, and delta-cells as determined by immunofluorescence and in situ hybridization, and is absent from exocrine pancreas.","method":"In situ hybridization and immunofluorescence on mouse pancreatic sections; co-staining with insulin, glucagon, and somatostatin antibodies","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 3 — direct localization in native tissue with multiple markers","pmids":["9287044"],"is_preprint":false},{"year":2000,"finding":"Kir6.2 knockout mice and dominant-negative Kir6.2 transgenic mice demonstrate that K(ATP) channels are the major determinant of beta-cell resting membrane potential; both glucose- and sulphonylurea-induced membrane depolarization, calcium rises, and insulin secretion require closure of K(ATP) channels; K(ATP) channels are also important for beta-cell survival and islet architecture.","method":"Kir6.2 knockout and dominant-negative transgenic mice; glucose tolerance tests, calcium imaging, insulin secretion assays","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — genetic KO and dominant-negative mouse models with multiple orthogonal phenotypic readouts, replicated","pmids":["10868950"],"is_preprint":false},{"year":2001,"finding":"Kir6.2 subunit mediates the depression of cardiac excitability and contractility induced by K+ channel openers (pinacidil, P-1075); ventricular cells from Kir6.2 knockout mice lack sarcolemmal K(ATP) channels and do not respond to K+ channel openers, while arterial smooth muscle K(ATP) channels (composed of Kir6.1) are unaffected.","method":"Kir6.2 knockout mice; electrophysiology, gene transfer rescue, contractility assays, vascular smooth muscle studies","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — KO mouse with rescue by gene transfer and multiple physiological readouts","pmids":["11282890"],"is_preprint":false},{"year":2003,"finding":"Cysteine-scanning mutagenesis identified R50 (N-terminus) and K185 (C-terminus) as residues that interact directly with ATP in the Kir6.2 binding site; K185 interacts primarily with the beta-phosphate and R50 with the gamma-phosphate of ATP.","method":"Cysteine-scanning mutagenesis of Kir6.2 combined with charged thiol-modifying reagents (MTSEA/MTSES); electrophysiology; molecular modeling","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — cysteine-scanning with chemical modification and ATP analog testing","pmids":["12805206"],"is_preprint":false},{"year":2002,"finding":"Kir6.2 mRNA and protein are widely expressed in rat brain neurons (including mitral cells, pontine nucleus, motor nuclei) and in glial cells (astrocytes and oligodendrocytes); immunoelectron microscopy shows Kir6.2 protein localizes to endoplasmic reticulum, Golgi apparatus, and plasma membranes of neurons and glia.","method":"Immunohistochemistry, in situ hybridization, double staining with GFAP, immunoelectron microscopy","journal":"Brain research. Molecular brain research","confidence":"Medium","confidence_rationale":"Tier 3 — direct localization with multiple methods but functional consequence not directly tested","pmids":["12007828"],"is_preprint":false},{"year":2003,"finding":"R201 and K185 in the C-terminus of Kir6.2 mediate inhibition by adenine nucleotides via electrostatic interactions with phosphate groups; R201 interacts with the alpha-phosphate to stabilize a closed configuration, and K185 interacts with the beta-phosphate to destabilize channel openings in a state-independent fashion.","method":"Site-directed mutagenesis at R201, K185, R192, R50; patch-clamp electrophysiology with ATP, ADP, AMP","journal":"Biophysical journal","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with multiple nucleotide analogs and kinetic modeling","pmids":["12524280"],"is_preprint":false},{"year":2002,"finding":"Allosteric modulation of Kir6.2 by intracellular H+ and ATP involves His175 (proton sensing) and Lys185 (ATP sensing); mutation of His175 eliminates pH effects on ATP sensitivity, and K185E eliminates the ATP-dependent modulation of pH sensitivity, demonstrating direct interaction between the two regulatory sites.","method":"Site-directed mutagenesis (H175, K185) in Kir6.2+/-SUR1; patch-clamp electrophysiology over pH range","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with quantitative functional analysis of allosteric coupling","pmids":["12205184"],"is_preprint":false},{"year":2003,"finding":"Kir6.2-knockout mice lack ischemic preconditioning-induced protection of myocardial bioenergetics (ATP turnover, creatine kinase-catalyzed phosphotransfer, and contractile recovery), establishing that Kir6.2-containing K(ATP) channels are integral to preconditioning-induced cardiac energetic protection.","method":"Kir6.2 KO mice; 18O-assisted 31P-NMR spectroscopy; ischemia-reperfusion protocol; contractile measurements","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"High","confidence_rationale":"Tier 2 — KO mouse with multimodal energy metabolism assessment","pmids":["12598229"],"is_preprint":false},{"year":2004,"finding":"Heterozygous gain-of-function mutations in Kir6.2 (KCNJ11) cause permanent neonatal diabetes mellitus by reducing channel inhibition by ATP; mutations causing more severe reduction in ATP sensitivity (Q52R, V59G) cause additional neurological features (DEND syndrome), while milder mutations (R201C) cause diabetes alone, correlating disease severity with degree of K(ATP) current increase.","method":"Heterologous expression of wild-type and mutant Kir6.2/SUR1 in Xenopus oocytes; electrophysiology; simulated heterozygosity","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — functional reconstitution with multiple disease mutations and quantitative ATP sensitivity measurement","pmids":["15583126"],"is_preprint":false},{"year":2005,"finding":"KCNJ11 mutations causing neonatal diabetes (R201C, R201H, V59M, V59G) increase K(ATP) current in two ways: by decreasing ATP inhibition via Kir6.2 and by enhancing MgATP activation via SUR1 nucleotide-binding domains; the fraction of unblocked current at physiological MgATP correlates with clinical severity.","method":"Heterologous expression in Xenopus oocytes; electrophysiology with and without Mg2+; comparison of MgATP vs ATP effects","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 — functional reconstitution with multiple mutations and mechanistic dissection of Mg2+-dependent vs independent effects","pmids":["16087682"],"is_preprint":false},{"year":2005,"finding":"The I296L mutation at the internal mouth of the Kir6.2 pore (DEND syndrome) reduces ATP sensitivity indirectly by stabilizing the open state, implicating this region in Kir channel gating; the V59G mutation in the slide helix similarly acts by biasing toward open state rather than directly at the ATP binding site.","method":"Heterologous expression of mutant Kir6.2/SUR1 in Xenopus oocytes; single-channel and whole-cell electrophysiology; kinetic analysis","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1 — kinetic analysis combined with molecular modeling and functional reconstitution","pmids":["15864298"],"is_preprint":false},{"year":2005,"finding":"The F55L mutation in the Kir6.2 slide helix (congenital hyperinsulinism) reduces the intrinsic open probability of K(ATP) channels ~10-fold without affecting surface expression or nucleotide sensitivity; this low open probability can be reversed by PIP2 or oleoyl-CoA application, identifying reduced phospholipid/acyl-CoA responsiveness as the mechanism.","method":"Reconstitution of mutant channels in COS cells; patch-clamp electrophysiology; PIP2/oleoyl-CoA application","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with pharmacological rescue identifying molecular mechanism","pmids":["16332676"],"is_preprint":false},{"year":2005,"finding":"Cardiac K(ATP) channels (Kir6.2/SUR2A) are less affected than pancreatic K(ATP) channels (Kir6.2/SUR1) by neonatal diabetes mutations (Q52R, R201H) because SUR2A-containing channels show much less Mg-nucleotide activation enhancement by the mutations; this explains why these gain-of-function mutations produce neurological and pancreatic but not cardiac phenotypes.","method":"Comparative electrophysiology of Kir6.2/SUR1 vs Kir6.2/SUR2A heterologously expressed in Xenopus oocytes with and without Mg2+","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — direct functional comparison with mechanistic explanation for tissue-specific phenotype","pmids":["16339180"],"is_preprint":false},{"year":2005,"finding":"3D structure of the purified Kir6.2-SUR1 K(ATP) channel complex at 18 Å resolution by single-particle electron microscopy reveals four SUR1 subunits embracing a central Kir6.2 tetramer in both transmembrane and cytosolic domains; ATP access cleft identified between adjacent SUR1 subunits; purified channel shows ATPase activity and supports Rb+ fluxes in liposomes.","method":"Heterologous expression and purification; single-particle electron microscopy; ATPase assay; liposome Rb+ flux assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — structural determination with functional validation by multiple methods","pmids":["16308567"],"is_preprint":false},{"year":2007,"finding":"The PIP2-binding site on Kir6.2 involves residues in the N-terminus (K39, N41, R54), transmembrane domain (K67), and C-terminus (R176, R177, E179, R301); PIP2 binding increases channel opening and decreases ATP binding/channel inhibition.","method":"Homology modeling, ligand docking, and site-directed mutagenesis of Kir6.2; electrophysiology","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — homology modeling validated by systematic mutagenesis with functional readout","pmids":["17673911"],"is_preprint":false},{"year":2002,"finding":"A conserved alpha-helical region (residues ~306-315) in the Kir6.2 C-terminus, particularly E308, I309, W311, and F315, forms a critical phospholipid-interaction domain; GFP-tagged Kir6.2 C-terminus associates with isolated membranes in a PIP2-dependent manner that is reduced by m1 receptor-mediated phospholipid depletion.","method":"GFP-fusion membrane association assay; systematic mutagenesis of C-terminal helix; muscarinic receptor-mediated PIP2 depletion","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 1 — membrane association assay combined with systematic mutagenesis","pmids":["12034765"],"is_preprint":false},{"year":2012,"finding":"SUR1 residue E203 and Kir6.2 residue Q52 are in close proximity and interact to modulate ATP sensitivity; E203K/Q52E double mutant channels show ~100-fold higher ATP sensitivity; cross-linking of E203C/Q52C locks the channel in a closed state reversible by reducing agents, demonstrating this interaction dynamically regulates channel gating.","method":"Charge-swap mutagenesis; cysteine cross-linking with oxidizing/reducing agents; electrophysiology in Xenopus oocytes","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 1 — cross-linking mutagenesis with functional validation demonstrating direct subunit interaction","pmids":["22802363"],"is_preprint":false},{"year":2005,"finding":"High-affinity repaglinide binding (~150-fold increase vs SUR1 alone) requires both Kir6.2 co-expression with SUR1 and an intact Kir6.2 N-terminus; deletion of Kir6.2 N-terminal 14 residues abolishes high-affinity repaglinide binding, indicating that Kir6.2 causes a conformational change in SUR1 or contributes directly to the repaglinide binding site.","method":"Radioligand binding ([3H]-glibenclamide) with co-expressed Kir6.2/SUR1 in membranes; N-terminal deletion mutants; whole-cell patch-clamp","journal":"British journal of pharmacology","confidence":"High","confidence_rationale":"Tier 1 — binding assay combined with mutagenesis and functional electrophysiology","pmids":["15678092"],"is_preprint":false},{"year":2011,"finding":"Progressive N-terminal truncation of Kir6.2 impairs transduction of sulphonylurea (glibenclamide, repaglinide) binding into channel closure and accelerates glibenclamide dissociation, establishing that the Kir6.2 N-terminus is required for coupling drug binding at SUR1 to pore closure.","method":"Progressive N-terminal truncation of Kir6.2 (up to 20 amino acids); equilibrium [3H]-glibenclamide binding; inside-out patch-clamp in HEK cells","journal":"Naunyn-Schmiedeberg's archives of pharmacology","confidence":"High","confidence_rationale":"Tier 1 — systematic truncation with binding kinetics and electrophysiology","pmids":["22083559"],"is_preprint":false},{"year":2013,"finding":"βIV-spectrin directly associates with Kir6.2 in pancreatic islets and recruits CaMKII; CaMKII directly phosphorylates Kir6.2 at Thr224, and this phosphorylation inhibits K(ATP) channel function; βIV-spectrin mutant mice lacking CaMKII-binding motifs show aberrant Kir6.2 phosphorylation and altered insulin regulation.","method":"Co-immunoprecipitation; in vitro phosphorylation assay; mutagenesis of T224; electrophysiology; βIV-spectrin mutant mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, in vitro kinase assay with site mutagenesis, and in vivo mouse model converging on same finding","pmids":["24101510"],"is_preprint":false},{"year":2020,"finding":"Kir6.2 is palmitoylated at Cys166; palmitoylation promotes channel opening by increasing open time and enhancing PIP2 sensitivity without affecting surface expression; mutagenesis of C166 prevents palmitoylation effects; clinical KCNJ11 variants affecting C166 show gain-of-function consistent with enhanced PIP2 interaction.","method":"Acyl-biotin exchange assay; patch-clamp electrophysiology in transfected cells, INS-1 cells, and cardiac myocytes; C166 mutagenesis; molecular modeling; palmitoylation inhibition/palmitate preincubation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — biochemical palmitoylation detection combined with mutagenesis, functional assay in multiple cell types, and structural modeling","pmids":["32332165"],"is_preprint":false},{"year":2006,"finding":"Targeted expression of Kir6.2 in mitochondria of HEK293 and HL-1 cells increases mitochondrial K+ influx, substantially improves cell viability after hypoxic stress, and attenuates mitochondrial Ca2+ accumulation; an inactive Kir6.2 mutant abolishes these protective effects.","method":"Mitochondrial-targeted Kir6.2 expression via pCMV/mito/GFP vector; PBFI-AM K+ fluorescence; LDH release assay; rhod-2 mitochondrial Ca2+ measurement; inactive mutant control","journal":"The Journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 — direct organelle-targeted expression with inactive mutant control and multiple readouts","pmids":["16959852"],"is_preprint":false},{"year":2004,"finding":"Kir6.2 gene expression in intestinal progenitor cells is regulated by transcription factors Foxa2 (via a -1364/-1210 element) and Sp1/Sp3 (via a -1035/-939 element) in the Kir6.2 promoter; Isl-1 attenuates Foxa2 overexpression to enable Kir6.2 expression; knockdown of Isl-1 in beta-cells reduces Kir6.2 protein.","method":"Luciferase reporter assay; EMSA; Pdx-1/Isl-1 overexpression; Isl-1 siRNA knockdown in RIN-5F cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — promoter dissection with EMSA and functional reporter, validated by siRNA knockdown","pmids":["15528203"],"is_preprint":false},{"year":2016,"finding":"Memantine blocks Kir6.2-containing K(ATP) channels (inhibits Kir6.2 expressed in neuro2A cells, elevating intracellular Ca2+); Kir6.2 knockout mice exhibit severe memory deficits and impaired hippocampal LTP that cannot be rescued by memantine, establishing Kir6.2 as a target for memantine-mediated memory enhancement.","method":"Kir6.2 overexpression in neuro2A cells with Ca2+ measurement; Kir6.2 KO mice; hippocampal LTP recording; CaMKII activity assay; pinacidil rescue experiment","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with LTP and behavioral phenotype combined with pharmacological intervention and Ca2+ measurement","pmids":["27777420"],"is_preprint":false},{"year":1999,"finding":"Gene delivery of Kir6.2/SUR2A into cells lacking native K(ATP) channels confers resistance to metabolic (hypoxia-reoxygenation) stress by preventing intracellular Ca2+ loading; this effect is blocked by 5-hydroxydecanoate and requires the K+ channel activator pinacidil, establishing a direct causal link between Kir6.2/SUR2A channel activation and Ca2+ homeostasis under stress.","method":"Gene transfer of Kir6.2/SUR2A into somatic cells; fluorescent Ca2+ measurement; pharmacological inhibition with 5-HD","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function gene transfer with pharmacological validation","pmids":["10224235"],"is_preprint":false},{"year":2017,"finding":"NFκB signaling elevates KCNJ11 expression in hepatocellular carcinoma; KCNJ11 protein interacts with lactate dehydrogenase A (LDHA) and enhances its enzymatic activity, promoting tumor cell proliferation, reducing apoptosis, and increasing invasion; pharmacological inhibition of LDHA compromises these KCNJ11-dependent oncogenic functions.","method":"NFκB inhibition; KCNJ11 knockdown; co-immunoprecipitation of KCNJ11-LDHA complex; LDHA enzymatic activity assay; cell proliferation/apoptosis/invasion assays; pharmacological LDHA inhibition","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP identifying interaction combined with enzymatic assay and functional rescue","pmids":["29108994"],"is_preprint":false}],"current_model":"KCNJ11 (Kir6.2) forms the pore-forming subunit of the octameric K(ATP) channel by assembling as a tetramer with four SUR subunits (SUR1 in pancreatic beta-cells, SUR2A in heart); ATP inhibits channel activity by binding directly to Kir6.2 at a site involving N-terminal residues (R50, I49) and C-terminal residues (K185, R201, E179), while MgADP and sulphonylureas act via SUR; channel gating is further modulated by PIP2 binding to a conserved site on Kir6.2, palmitoylation at Cys166, PKA phosphorylation at Ser372, CaMKII phosphorylation at Thr224 (mediated by a βIV-spectrin scaffold), and intracellular pH; in pancreatic beta-cells, channel closure links glucose metabolism to insulin secretion, and gain-of-function mutations reduce ATP sensitivity causing neonatal diabetes (with neurological complications when the open-state stabilization is particularly severe), while loss-of-function mutations cause congenital hyperinsulinism."},"narrative":{"teleology":[{"year":1997,"claim":"Whether the ATP-inhibitory site resides on the pore subunit or the accessory SUR was unknown; truncation of the Kir6.2 C-terminus produced functional ATP-sensitive channels without SUR1, establishing that Kir6.2 itself harbors the primary ATP gate.","evidence":"Expression of Kir6.2ΔC26 in Xenopus oocytes; electrophysiology","pmids":["9144288"],"confidence":"High","gaps":["Exact residues forming the ATP binding pocket not yet identified","SUR contribution to ATP sensitivity modulation not fully dissected"]},{"year":1997,"claim":"The identity of pore-lining residues and their influence on gating was unresolved; N160 was shown to line the pore and mediate inward rectification, and its mutation altered ATP sensitivity indirectly by changing open probability rather than ATP binding affinity.","evidence":"Site-directed mutagenesis of N160 in Kir6.2/SUR1; electrophysiology in COSm6 cells","pmids":["9236207"],"confidence":"High","gaps":["Full pore structure unknown at this resolution","How open probability modulates apparent ATP sensitivity only conceptually understood"]},{"year":1999,"claim":"The contribution of Kir6.2 structural domains to ATP binding and gating was mapped: the N-terminus controls interburst gating and couples SUR1 drug binding to pore closure, while R50 in the N-terminus cooperates with C-terminal E179 for ATP inhibition.","evidence":"Systematic N-terminal deletions, R50 mutagenesis, and synergy analysis in Xenopus oocytes; single-channel kinetics","pmids":["9831713","10381582","10049691"],"confidence":"High","gaps":["Direct contact between R50 and ATP not yet proven by accessibility methods","Mechanism coupling N-terminal conformational change to SUR1 drug binding unresolved"]},{"year":1999,"claim":"How the channel assembles with different SUR isoforms was unclear; the Kir6.2 proximal C-terminus and M2 domain were shown to mediate physical association with SUR2A, defining the cardiac channel assembly interface.","evidence":"Co-immunoprecipitation of in vitro-translated Kir6.2 and SUR2A; C-terminal deletion mutants","pmids":["10093054"],"confidence":"Medium","gaps":["In vitro translation system may not recapitulate native assembly","No reciprocal mapping on SUR2A side"]},{"year":1999,"claim":"Whether Kir6.2 channel activity is regulated by second-messenger cascades was unknown; PKA was shown to phosphorylate Kir6.2 at Ser372 downstream of Gs-coupled receptors, increasing channel activity.","evidence":"Mutagenesis of PKA sites; phosphorylation assays in oocytes and intact cells; electrophysiology","pmids":["10469651"],"confidence":"High","gaps":["Physiological context of PKA-mediated regulation in beta-cell insulin secretion not directly tested","Whether other kinases also target Kir6.2 unknown"]},{"year":2000,"claim":"The in vivo role of Kir6.2 in beta-cell physiology was unproven; Kir6.2 knockout and dominant-negative transgenic mice demonstrated that K_ATP channels set beta-cell resting potential and are required for glucose- and sulfonylurea-stimulated insulin secretion.","evidence":"Kir6.2 KO and dominant-negative transgenic mice; glucose tolerance, calcium imaging, insulin secretion","pmids":["10868950"],"confidence":"High","gaps":["Compensatory changes in KO mice not fully characterized","Role in alpha- and delta-cell physiology not dissected"]},{"year":2001,"claim":"Whether Kir6.2 is the essential pore subunit of cardiac sarcolemmal K_ATP channels was uncertain; Kir6.2 KO mice lacked cardiac K_ATP currents and K+ channel opener responses, while vascular Kir6.1-based channels were unaffected, establishing tissue-specific subunit usage.","evidence":"Kir6.2 KO mice; electrophysiology, gene transfer rescue, contractility and vascular studies","pmids":["11282890"],"confidence":"High","gaps":["Whether Kir6.2 also contributes to vascular or mitochondrial channels in vivo not resolved"]},{"year":2002,"claim":"PIP2 regulation of Kir6.2 was known but the structural basis was unclear; a conserved C-terminal alpha-helix (residues 306–315) was identified as a phospholipid-interaction domain, and allosteric coupling between pH sensing (His175) and ATP inhibition (Lys185) was demonstrated.","evidence":"GFP-fusion membrane association assay with mutagenesis; pH-titration electrophysiology with H175/K185 mutants","pmids":["12034765","12205184"],"confidence":"High","gaps":["Full PIP2 binding site not yet mapped","Whether pH regulation is physiologically relevant in beta-cells not tested"]},{"year":2003,"claim":"The identities of residues directly contacting ATP were unknown; cysteine-scanning and mutagenesis established that R50 contacts the γ-phosphate, K185 the β-phosphate, and R201 the α-phosphate of ATP, defining the complete inhibitory binding site.","evidence":"Cysteine-scanning mutagenesis with charged thiol reagents; electrophysiology with ATP analogs; site-directed mutagenesis with AMP/ADP/ATP","pmids":["12805206","12524280"],"confidence":"High","gaps":["No atomic-resolution structure of the ATP binding pocket","Conformational changes upon ATP binding not directly visualized"]},{"year":2003,"claim":"The role of cardiac K_ATP channels in ischemic preconditioning was debated; Kir6.2 KO mice failed to develop preconditioning-induced bioenergetic protection, establishing Kir6.2-containing channels as essential mediators.","evidence":"Kir6.2 KO mice; 18O-assisted 31P-NMR spectroscopy; ischemia-reperfusion with contractile measurements","pmids":["12598229"],"confidence":"High","gaps":["Whether sarcolemmal or mitochondrial Kir6.2 channels mediate preconditioning not distinguished"]},{"year":2004,"claim":"The genetic basis of permanent neonatal diabetes was being elucidated; heterozygous gain-of-function KCNJ11 mutations were shown to cause neonatal diabetes by reducing ATP inhibition, with mutation severity correlating to clinical phenotype—mild mutations causing diabetes alone and severe mutations causing DEND syndrome.","evidence":"Heterologous expression of disease mutations in Xenopus oocytes; electrophysiology with simulated heterozygosity","pmids":["15583126"],"confidence":"High","gaps":["Why some mutations cause transient vs permanent neonatal diabetes unknown","In vivo confirmation in mouse models not yet done"]},{"year":2005,"claim":"Multiple mechanistic advances converged: disease mutations were shown to act both by reducing direct ATP block on Kir6.2 and by enhancing MgATP activation via SUR1; tissue specificity was explained by differential SUR2A vs SUR1 responses; loss-of-function (hyperinsulinism) mutations were shown to reduce PIP2 sensitivity; the first 3D structure of the octameric complex was obtained at 18 Å; and the Kir6.2 N-terminus was required for high-affinity drug binding.","evidence":"Comparative electrophysiology of SUR1 vs SUR2A channels; F55L reconstitution with PIP2 rescue; single-particle EM at 18 Å with ATPase and Rb+ flux validation; radioligand binding with N-terminal deletions","pmids":["16087682","16339180","16332676","16308567","15678092","15864298"],"confidence":"High","gaps":["High-resolution structure needed to resolve ATP and PIP2 binding sites","How MgATP activation through SUR1 NBDs is mechanistically coupled to Kir6.2 gating unknown"]},{"year":2007,"claim":"The full PIP2 binding site was mapped across both termini and the transmembrane domain, revealing a distributed interaction surface involving K39, R54, K67, R176, R177, and R301.","evidence":"Homology modeling with ligand docking validated by systematic mutagenesis and electrophysiology","pmids":["17673911"],"confidence":"High","gaps":["No direct structural visualization of PIP2 bound to Kir6.2","Relative contribution of each residue to PIP2 affinity not quantified"]},{"year":2012,"claim":"How SUR1 communicates with the Kir6.2 pore was structurally unresolved; charge-swap and cysteine cross-linking between SUR1-E203 and Kir6.2-Q52 demonstrated a direct physical interface that dynamically regulates ATP-dependent gating.","evidence":"Charge-swap mutagenesis and oxidative cross-linking in Xenopus oocytes; electrophysiology","pmids":["22802363"],"confidence":"High","gaps":["Whether additional SUR1–Kir6.2 contact points exist beyond E203–Q52 not known","Structural basis at atomic resolution not available"]},{"year":2013,"claim":"Whether scaffold proteins recruit kinases to Kir6.2 was unknown; βIV-spectrin was shown to associate with Kir6.2 and recruit CaMKII, which phosphorylates Thr224 to inhibit channel activity, providing a new regulatory mechanism in islets.","evidence":"Co-IP; in vitro kinase assay; T224 mutagenesis; electrophysiology; βIV-spectrin mutant mice","pmids":["24101510"],"confidence":"High","gaps":["Whether CaMKII-mediated phosphorylation regulates Kir6.2 in neurons or heart not tested","Signaling cascades upstream of CaMKII at the channel not defined"]},{"year":2020,"claim":"Post-translational lipid modification of Kir6.2 was unexplored; palmitoylation at Cys166 was discovered to promote channel opening by enhancing PIP2 sensitivity, adding a lipid-based regulatory layer.","evidence":"Acyl-biotin exchange; patch-clamp in transfected cells, INS-1 cells, and cardiomyocytes; C166 mutagenesis; molecular modeling","pmids":["32332165"],"confidence":"High","gaps":["Which palmitoyl transferase modifies Kir6.2 unknown","Whether palmitoylation is dynamically regulated by metabolic state not established"]},{"year":null,"claim":"Major open questions include: the high-resolution structural basis of ATP/PIP2 binding and gating transitions; how palmitoylation is enzymatically regulated; the precise mechanism by which SUR nucleotide-binding domain activation is transduced to Kir6.2 pore opening; and whether Kir6.2 functions in mitochondrial membranes in vivo.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution cryo-EM structure with bound ATP and PIP2 simultaneously resolved in the timeline","Enzymatic palmitoylation/depalmitoylation machinery not identified","In vivo evidence for mitochondrial Kir6.2 remains indirect"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,8,9]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[21,22,27]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[7,8,9,11]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[11]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[11]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,1,8,9]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,8,26]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[30]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[15,16,18]}],"complexes":["K_ATP channel (Kir6.2/SUR1)","K_ATP channel (Kir6.2/SUR2A)"],"partners":["ABCC8","ABCC9","SPTBN4","CAMK2A","LDHA"],"other_free_text":[]},"mechanistic_narrative":"KCNJ11 (Kir6.2) encodes the pore-forming subunit of ATP-sensitive potassium (K_ATP) channels, coupling cellular metabolic status to membrane excitability across pancreatic islet cells, cardiomyocytes, and neurons. Kir6.2 assembles as a tetramer with four sulfonylurea receptor subunits (SUR1 or SUR2A) to form an octameric channel complex; ATP directly inhibits the channel by binding a site composed of N-terminal (R50) and C-terminal (K185, R201) residues on Kir6.2, while MgADP activation and sulfonylurea-mediated closure are transduced through SUR, with the Kir6.2 N-terminus required for coupling drug binding to pore gating [PMID:9144288, PMID:12805206, PMID:12524280, PMID:22083559]. Channel open probability is further tuned by PIP2 binding to a distributed site spanning both termini and the transmembrane domain, by palmitoylation at Cys166 that enhances PIP2 sensitivity, by PKA phosphorylation at Ser372, by CaMKII phosphorylation at Thr224 scaffolded by βIV-spectrin, and by intracellular pH sensed through His175 [PMID:17673911, PMID:32332165, PMID:10469651, PMID:24101510, PMID:12205184]. Gain-of-function mutations that reduce ATP sensitivity cause permanent neonatal diabetes—with severity ranging from isolated diabetes (R201C/H) to diabetes with developmental delay, epilepsy, and neonatal diabetes (DEND syndrome; Q52R, V59G, I296L)—while loss-of-function mutations (e.g., F55L) cause congenital hyperinsulinism; in the heart, Kir6.2-containing channels mediate ischemic preconditioning and stress-induced cardioprotection [PMID:15583126, PMID:16332676, PMID:12598229]."},"prefetch_data":{"uniprot":{"accession":"Q14654","full_name":"ATP-sensitive inward rectifier potassium channel 11","aliases":["IKATP","Inward rectifier K(+) channel Kir6.2","Potassium channel, inwardly rectifying subfamily J member 11"],"length_aa":390,"mass_kda":43.5,"function":"Inward rectifier potassium channel that forms the pore of ATP-sensitive potassium channels (KATP), regulating potassium permeability as a function of cytoplasmic ATP and ADP concentrations in many different cells (PubMed:29286281, PubMed:34815345). Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by extracellular barium (By similarity). In pancreatic cells, it forms KATP channels with ABCC8/SUR1 (PubMed:29286281, PubMed:34815345). Can form cardiac and smooth muscle-type KATP channels with ABCC9","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/Q14654/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCNJ11","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCNJ11","total_profiled":1310},"omim":[{"mim_id":"618858","title":"DIABETES MELLITUS, PERMANENT NEONATAL, 4; PNDM4","url":"https://www.omim.org/entry/618858"},{"mim_id":"618857","title":"DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3","url":"https://www.omim.org/entry/618857"},{"mim_id":"618856","title":"DIABETES MELLITUS, PERMANENT NEONATAL, 2; PNDM2","url":"https://www.omim.org/entry/618856"},{"mim_id":"616329","title":"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13; MODY13","url":"https://www.omim.org/entry/616329"},{"mim_id":"610582","title":"DIABETES MELLITUS, TRANSIENT NEONATAL, 3; TNDM3","url":"https://www.omim.org/entry/610582"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"skeletal muscle","ntpm":106.1},{"tissue":"tongue","ntpm":40.3}],"url":"https://www.proteinatlas.org/search/KCNJ11"},"hgnc":{"alias_symbol":["Kir6.2","BIR"],"prev_symbol":[]},"alphafold":{"accession":"Q14654","domains":[{"cath_id":"1.10.287.70","chopping":"53-173","consensus_level":"high","plddt":91.7693,"start":53,"end":173},{"cath_id":"2.60.40.1400","chopping":"178-347","consensus_level":"high","plddt":92.5286,"start":178,"end":347}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14654","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q14654-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q14654-F1-predicted_aligned_error_v6.png","plddt_mean":83.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCNJ11","jax_strain_url":"https://www.jax.org/strain/search?query=KCNJ11"},"sequence":{"accession":"Q14654","fasta_url":"https://rest.uniprot.org/uniprotkb/Q14654.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q14654/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14654"}},"corpus_meta":[{"pmid":"9144288","id":"PMC_9144288","title":"Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.","date":"1997","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9144288","citation_count":669,"is_preprint":false},{"pmid":"9525868","id":"PMC_9525868","title":"A single BIR domain of XIAP sufficient for inhibiting caspases.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9525868","citation_count":507,"is_preprint":false},{"pmid":"8923010","id":"PMC_8923010","title":"Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy.","date":"1996","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8923010","citation_count":343,"is_preprint":false},{"pmid":"10407412","id":"PMC_10407412","title":"An exegesis of IAPs: salvation and surprises from BIR motifs.","date":"1999","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10407412","citation_count":290,"is_preprint":false},{"pmid":"18162508","id":"PMC_18162508","title":"Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population.","date":"2007","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/18162508","citation_count":225,"is_preprint":false},{"pmid":"10934209","id":"PMC_10934209","title":"NMR structure and mutagenesis of the third Bir domain of the inhibitor of apoptosis protein XIAP.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10934209","citation_count":212,"is_preprint":false},{"pmid":"10209096","id":"PMC_10209096","title":"Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis.","date":"1999","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/10209096","citation_count":204,"is_preprint":false},{"pmid":"9867219","id":"PMC_9867219","title":"Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians.","date":"1998","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/9867219","citation_count":200,"is_preprint":false},{"pmid":"15583126","id":"PMC_15583126","title":"Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15583126","citation_count":193,"is_preprint":false},{"pmid":"16609879","id":"PMC_16609879","title":"Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.","date":"2006","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/16609879","citation_count":171,"is_preprint":false},{"pmid":"11282890","id":"PMC_11282890","title":"Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice.","date":"2001","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/11282890","citation_count":158,"is_preprint":false},{"pmid":"10469651","id":"PMC_10469651","title":"PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10469651","citation_count":148,"is_preprint":false},{"pmid":"22701567","id":"PMC_22701567","title":"Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22701567","citation_count":145,"is_preprint":false},{"pmid":"20424228","id":"PMC_20424228","title":"Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians.","date":"2010","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/20424228","citation_count":141,"is_preprint":false},{"pmid":"16308567","id":"PMC_16308567","title":"3-D structural and functional characterization of the purified KATP channel complex Kir6.2-SUR1.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16308567","citation_count":138,"is_preprint":false},{"pmid":"15718250","id":"PMC_15718250","title":"Relapsing diabetes can result from moderately activating mutations in KCNJ11.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15718250","citation_count":136,"is_preprint":false},{"pmid":"10868950","id":"PMC_10868950","title":"Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice.","date":"2000","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/10868950","citation_count":128,"is_preprint":false},{"pmid":"32027066","id":"PMC_32027066","title":"Update of variants identified in the pancreatic β-cell KATP channel genes KCNJ11 and ABCC8 in individuals with congenital hyperinsulinism and diabetes.","date":"2020","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/32027066","citation_count":126,"is_preprint":false},{"pmid":"14512414","id":"PMC_14512414","title":"Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14512414","citation_count":126,"is_preprint":false},{"pmid":"9236207","id":"PMC_9236207","title":"Control of rectification and gating of cloned KATP channels by the Kir6.2 subunit.","date":"1997","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9236207","citation_count":119,"is_preprint":false},{"pmid":"12598229","id":"PMC_12598229","title":"Knockout of Kir6.2 negates ischemic preconditioning-induced protection of myocardial energetics.","date":"2003","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12598229","citation_count":113,"is_preprint":false},{"pmid":"16670688","id":"PMC_16670688","title":"KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.","date":"2006","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/16670688","citation_count":111,"is_preprint":false},{"pmid":"11329368","id":"PMC_11329368","title":"Two kinds of BIR-containing protein - inhibitors of apoptosis, or required for mitosis.","date":"2001","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/11329368","citation_count":98,"is_preprint":false},{"pmid":"20685672","id":"PMC_20685672","title":"ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism.","date":"2010","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20685672","citation_count":91,"is_preprint":false},{"pmid":"15864298","id":"PMC_15864298","title":"A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome.","date":"2005","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/15864298","citation_count":85,"is_preprint":false},{"pmid":"26448950","id":"PMC_26448950","title":"KCNJ11: Genetic Polymorphisms and Risk of Diabetes Mellitus.","date":"2015","source":"Journal of diabetes research","url":"https://pubmed.ncbi.nlm.nih.gov/26448950","citation_count":82,"is_preprint":false},{"pmid":"10381582","id":"PMC_10381582","title":"Involvement of the n-terminus of Kir6.2 in coupling to the sulphonylurea receptor.","date":"1999","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10381582","citation_count":82,"is_preprint":false},{"pmid":"21674179","id":"PMC_21674179","title":"Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations.","date":"2011","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/21674179","citation_count":73,"is_preprint":false},{"pmid":"30766663","id":"PMC_30766663","title":"Targeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer Treatment.","date":"2019","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/30766663","citation_count":71,"is_preprint":false},{"pmid":"10093054","id":"PMC_10093054","title":"Physical association between recombinant cardiac ATP-sensitive K+ channel subunits Kir6.2 and SUR2A.","date":"1999","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/10093054","citation_count":69,"is_preprint":false},{"pmid":"12805206","id":"PMC_12805206","title":"Identification of residues contributing to the ATP binding site of Kir6.2.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12805206","citation_count":69,"is_preprint":false},{"pmid":"10049691","id":"PMC_10049691","title":"The N-terminus of KIR6.2 limits spontaneous bursting and modulates the ATP-inhibition of KATP channels.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10049691","citation_count":68,"is_preprint":false},{"pmid":"9287044","id":"PMC_9287044","title":"Localization of the ATP-sensitive K+ channel subunit Kir6.2 in mouse pancreas.","date":"1997","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/9287044","citation_count":68,"is_preprint":false},{"pmid":"22385882","id":"PMC_22385882","title":"KCNJ11 gene E23K variant and therapeutic response to sulfonylureas.","date":"2011","source":"European journal of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22385882","citation_count":67,"is_preprint":false},{"pmid":"16087682","id":"PMC_16087682","title":"Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16087682","citation_count":67,"is_preprint":false},{"pmid":"15579781","id":"PMC_15579781","title":"Hyperinsulinism of infancy: novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity.","date":"2004","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15579781","citation_count":66,"is_preprint":false},{"pmid":"27033559","id":"PMC_27033559","title":"Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.","date":"2016","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/27033559","citation_count":66,"is_preprint":false},{"pmid":"20922570","id":"PMC_20922570","title":"Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.","date":"2010","source":"Reviews in endocrine & metabolic disorders","url":"https://pubmed.ncbi.nlm.nih.gov/20922570","citation_count":65,"is_preprint":false},{"pmid":"17673911","id":"PMC_17673911","title":"Identification of the PIP2-binding site on Kir6.2 by molecular modelling and functional analysis.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17673911","citation_count":64,"is_preprint":false},{"pmid":"16332676","id":"PMC_16332676","title":"A novel KCNJ11 mutation associated with congenital hyperinsulinism reduces the intrinsic open probability of beta-cell ATP-sensitive potassium channels.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16332676","citation_count":64,"is_preprint":false},{"pmid":"9143281","id":"PMC_9143281","title":"A BIR motif containing gene of African swine fever virus, 4CL, is nonessential for growth in vitro and viral virulence.","date":"1997","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/9143281","citation_count":61,"is_preprint":false},{"pmid":"12007828","id":"PMC_12007828","title":"Localization of pore-forming subunit of the ATP-sensitive K(+)-channel, Kir6.2, in rat brain neurons and glial cells.","date":"2002","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/12007828","citation_count":57,"is_preprint":false},{"pmid":"15565284","id":"PMC_15565284","title":"Current status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes.","date":"2004","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15565284","citation_count":56,"is_preprint":false},{"pmid":"12034765","id":"PMC_12034765","title":"Structural and functional determinants of conserved lipid interaction domains of inward rectifying Kir6.2 channels.","date":"2002","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12034765","citation_count":54,"is_preprint":false},{"pmid":"10224235","id":"PMC_10224235","title":"Gene delivery of Kir6.2/SUR2A in conjunction with pinacidil handles intracellular Ca2+ homeostasis under metabolic stress.","date":"1999","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/10224235","citation_count":53,"is_preprint":false},{"pmid":"17021801","id":"PMC_17021801","title":"Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.","date":"2006","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17021801","citation_count":52,"is_preprint":false},{"pmid":"9831713","id":"PMC_9831713","title":"Involvement of the N-terminus of Kir6.2 in the inhibition of the KATP channel by ATP.","date":"1999","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9831713","citation_count":52,"is_preprint":false},{"pmid":"15910877","id":"PMC_15910877","title":"Focus on Kir6.2: a key component of the ATP-sensitive potassium channel.","date":"2005","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/15910877","citation_count":51,"is_preprint":false},{"pmid":"18664331","id":"PMC_18664331","title":"Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.","date":"2008","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/18664331","citation_count":51,"is_preprint":false},{"pmid":"34119519","id":"PMC_34119519","title":"Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease.","date":"2021","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34119519","citation_count":50,"is_preprint":false},{"pmid":"16731833","id":"PMC_16731833","title":"Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects.","date":"2006","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/16731833","citation_count":50,"is_preprint":false},{"pmid":"15485395","id":"PMC_15485395","title":"The BIR domain of IAP-like protein 2 is conformationally unstable: implications for caspase inhibition.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15485395","citation_count":46,"is_preprint":false},{"pmid":"29735985","id":"PMC_29735985","title":"The SERK3 elongated allele defines a role for BIR ectodomains in brassinosteroid signalling.","date":"2018","source":"Nature plants","url":"https://pubmed.ncbi.nlm.nih.gov/29735985","citation_count":44,"is_preprint":false},{"pmid":"27777420","id":"PMC_27777420","title":"Blockade of the KATP channel Kir6.2 by memantine represents a novel mechanism relevant to Alzheimer's disease therapy.","date":"2016","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/27777420","citation_count":42,"is_preprint":false},{"pmid":"14514634","id":"PMC_14514634","title":"NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker rat.","date":"2003","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/14514634","citation_count":41,"is_preprint":false},{"pmid":"17327377","id":"PMC_17327377","title":"Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings.","date":"2007","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17327377","citation_count":41,"is_preprint":false},{"pmid":"16530794","id":"PMC_16530794","title":"Behavioral phenotyping of mice lacking the K ATP channel subunit Kir6.2.","date":"2006","source":"Physiology & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/16530794","citation_count":41,"is_preprint":false},{"pmid":"12351459","id":"PMC_12351459","title":"Variations in insulin secretion in carriers of the E23K variant in the KIR6.2 subunit of the ATP-sensitive K(+) channel in the beta-cell.","date":"2002","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/12351459","citation_count":40,"is_preprint":false},{"pmid":"9307442","id":"PMC_9307442","title":"Burst kinetics of co-expressed Kir6.2/SUR1 clones: comparison of recombinant with native ATP-sensitive K+ channel behavior.","date":"1997","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/9307442","citation_count":40,"is_preprint":false},{"pmid":"12524280","id":"PMC_12524280","title":"Molecular basis for Kir6.2 channel inhibition by adenine nucleotides.","date":"2003","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12524280","citation_count":39,"is_preprint":false},{"pmid":"18239672","id":"PMC_18239672","title":"The mechanism of peptide-binding specificity of IAP BIR domains.","date":"2008","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/18239672","citation_count":36,"is_preprint":false},{"pmid":"14988278","id":"PMC_14988278","title":"Analysis of the type 2 diabetes-associated single nucleotide polymorphisms in the genes IRS1, KCNJ11, and PPARG2 in type 1 diabetes.","date":"2004","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/14988278","citation_count":35,"is_preprint":false},{"pmid":"32332165","id":"PMC_32332165","title":"Palmitoylation of the KATP channel Kir6.2 subunit promotes channel opening by regulating PIP2 sensitivity.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32332165","citation_count":32,"is_preprint":false},{"pmid":"24998494","id":"PMC_24998494","title":"Dual response of the KATP channels to staurosporine: a novel role of SUR2B, SUR1 and Kir6.2 subunits in the regulation of the atrophy in different skeletal muscle phenotypes.","date":"2014","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24998494","citation_count":32,"is_preprint":false},{"pmid":"23999295","id":"PMC_23999295","title":"The structure of XIAP BIR2: understanding the selectivity of the BIR domains.","date":"2013","source":"Acta crystallographica. Section D, Biological crystallography","url":"https://pubmed.ncbi.nlm.nih.gov/23999295","citation_count":31,"is_preprint":false},{"pmid":"21715697","id":"PMC_21715697","title":"The KATP channel Kir6.2 subunit content is higher in glycolytic than oxidative skeletal muscle fibers.","date":"2011","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21715697","citation_count":31,"is_preprint":false},{"pmid":"12205184","id":"PMC_12205184","title":"Allosteric modulation of the mouse Kir6.2 channel by intracellular H+ and ATP.","date":"2002","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12205184","citation_count":30,"is_preprint":false},{"pmid":"16339180","id":"PMC_16339180","title":"Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels.","date":"2005","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16339180","citation_count":30,"is_preprint":false},{"pmid":"21252625","id":"PMC_21252625","title":"Threonine 48 in the BIR domain of survivin is critical to its mitotic and anti-apoptotic activities and can be phosphorylated by CK2 in vitro.","date":"2011","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/21252625","citation_count":29,"is_preprint":false},{"pmid":"22802363","id":"PMC_22802363","title":"Engineered interaction between SUR1 and Kir6.2 that enhances ATP sensitivity in KATP channels.","date":"2012","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22802363","citation_count":28,"is_preprint":false},{"pmid":"15678092","id":"PMC_15678092","title":"Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels.","date":"2005","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15678092","citation_count":27,"is_preprint":false},{"pmid":"24101510","id":"PMC_24101510","title":"βIV-Spectrin and CaMKII facilitate Kir6.2 regulation in pancreatic beta cells.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24101510","citation_count":27,"is_preprint":false},{"pmid":"24710510","id":"PMC_24710510","title":"Quantitative assessment of the effect of KCNJ11 gene polymorphism on the risk of type 2 diabetes.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24710510","citation_count":27,"is_preprint":false},{"pmid":"27086753","id":"PMC_27086753","title":"Psychiatric morbidity in children with KCNJ11 neonatal diabetes.","date":"2016","source":"Diabetic medicine : a journal of the British Diabetic Association","url":"https://pubmed.ncbi.nlm.nih.gov/27086753","citation_count":26,"is_preprint":false},{"pmid":"30377186","id":"PMC_30377186","title":"Cognitive, Neurological, and Behavioral Features in Adults With KCNJ11 Neonatal Diabetes.","date":"2018","source":"Diabetes care","url":"https://pubmed.ncbi.nlm.nih.gov/30377186","citation_count":25,"is_preprint":false},{"pmid":"22591706","id":"PMC_22591706","title":"Association of KCNJ11 E23K gene polymorphism with hypoglycemia in sulfonylurea-treated type 2 diabetic patients.","date":"2012","source":"Diabetes research and clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/22591706","citation_count":23,"is_preprint":false},{"pmid":"17144666","id":"PMC_17144666","title":"Determination of the sequence specificity of XIAP BIR domains by screening a combinatorial peptide library.","date":"2006","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17144666","citation_count":23,"is_preprint":false},{"pmid":"28717589","id":"PMC_28717589","title":"Association of polymorphic markers of genes FTO, KCNJ11, CDKAL1, SLC30A8, and CDKN2B with type 2 diabetes mellitus in the Russian population.","date":"2017","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/28717589","citation_count":22,"is_preprint":false},{"pmid":"16959852","id":"PMC_16959852","title":"Targeted expression of Kir6.2 in mitochondria confers protection against hypoxic stress.","date":"2006","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16959852","citation_count":21,"is_preprint":false},{"pmid":"25625107","id":"PMC_25625107","title":"Association of KCNJ11 (E23K) gene polymorphism with susceptibility to type 2 diabetes in Iranian patients.","date":"2015","source":"Advanced biomedical research","url":"https://pubmed.ncbi.nlm.nih.gov/25625107","citation_count":21,"is_preprint":false},{"pmid":"31195986","id":"PMC_31195986","title":"Association of KCNJ11 rs5219 gene polymorphism with type 2 diabetes mellitus in a population of Syria: a case-control study.","date":"2019","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31195986","citation_count":21,"is_preprint":false},{"pmid":"17825556","id":"PMC_17825556","title":"Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats.","date":"2007","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/17825556","citation_count":20,"is_preprint":false},{"pmid":"24332549","id":"PMC_24332549","title":"E23K variant in KCNJ11 gene is associated with susceptibility to type 2 diabetes in the Mauritanian population.","date":"2013","source":"Primary care diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/24332549","citation_count":20,"is_preprint":false},{"pmid":"22083559","id":"PMC_22083559","title":"Importance of the Kir6.2 N-terminus for the interaction of glibenclamide and repaglinide with the pancreatic K(ATP) channel.","date":"2011","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22083559","citation_count":20,"is_preprint":false},{"pmid":"20694718","id":"PMC_20694718","title":"A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse.","date":"2010","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/20694718","citation_count":20,"is_preprint":false},{"pmid":"22957706","id":"PMC_22957706","title":"Identification of INS and KCNJ11 gene mutations in type 1B diabetes in Japanese children with onset of diabetes before 5 years of age.","date":"2012","source":"Pediatric diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/22957706","citation_count":20,"is_preprint":false},{"pmid":"31201216","id":"PMC_31201216","title":"Structure-Activity Relationships, Pharmacokinetics, and Pharmacodynamics of the Kir6.2/SUR1-Specific Channel Opener VU0071063.","date":"2019","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/31201216","citation_count":18,"is_preprint":false},{"pmid":"30171894","id":"PMC_30171894","title":"Deletion of Kir6.2/SUR1 potassium channels rescues diminishing of DA neurons via decreasing iron accumulation in PD.","date":"2018","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/30171894","citation_count":18,"is_preprint":false},{"pmid":"24996284","id":"PMC_24996284","title":"Association between E23K variant in KCNJ11 gene and new-onset diabetes after liver transplantation.","date":"2014","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/24996284","citation_count":18,"is_preprint":false},{"pmid":"29108994","id":"PMC_29108994","title":"NFκB mediated elevation of KCNJ11 promotes tumor progression of hepatocellular carcinoma through interaction of lactate dehydrogenase A.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29108994","citation_count":18,"is_preprint":false},{"pmid":"29564810","id":"PMC_29564810","title":"Kir6.2 Deficiency Promotes Mesencephalic Neural Precursor Cell Differentiation via Regulating miR-133b/GDNF in a Parkinson's Disease Mouse Model.","date":"2018","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/29564810","citation_count":17,"is_preprint":false},{"pmid":"9799413","id":"PMC_9799413","title":"Suppression of KATP currents by gene transfer of a dominant negative Kir6.2 construct.","date":"1998","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9799413","citation_count":16,"is_preprint":false},{"pmid":"22851715","id":"PMC_22851715","title":"Molecular mechanisms of chloroquine inhibition of heterologously expressed Kir6.2/SUR2A channels.","date":"2012","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22851715","citation_count":16,"is_preprint":false},{"pmid":"18335204","id":"PMC_18335204","title":"A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications.","date":"2008","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/18335204","citation_count":16,"is_preprint":false},{"pmid":"30467975","id":"PMC_30467975","title":"ADIPOQ, KCNJ11 and TCF7L2 polymorphisms in type 2 diabetes in Kyrgyz population: A case-control study.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30467975","citation_count":15,"is_preprint":false},{"pmid":"36401380","id":"PMC_36401380","title":"Association of KCNJ11 and ABCC8 single-nucleotide polymorphisms with type 2 diabetes mellitus in a Kinh Vietnamese population.","date":"2022","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36401380","citation_count":15,"is_preprint":false},{"pmid":"22082043","id":"PMC_22082043","title":"The effect of KCNJ11 polymorphism on the risk of type 2 diabetes: a global meta-analysis based on 49 case-control studies.","date":"2011","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22082043","citation_count":15,"is_preprint":false},{"pmid":"15528203","id":"PMC_15528203","title":"Regulation of ATP-sensitive potassium channel subunit Kir6.2 expression in rat intestinal insulin-producing progenitor cells.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15528203","citation_count":15,"is_preprint":false},{"pmid":"28330327","id":"PMC_28330327","title":"Role of GNB3, NET, KCNJ11, TCF7L2 and GRL genes single nucleotide polymorphism in the risk prediction of type 2 diabetes mellitus.","date":"2016","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/28330327","citation_count":14,"is_preprint":false},{"pmid":"29192194","id":"PMC_29192194","title":"Solution structure and interaction with copper in vitro and in living cells of the first BIR domain of XIAP.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29192194","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52657,"output_tokens":7932,"usd":0.138476},"stage2":{"model":"claude-opus-4-6","input_tokens":11681,"output_tokens":4183,"usd":0.24447},"total_usd":0.382946,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"Truncation of Kir6.2 (removing the last 26 C-terminal residues) allows it to form functional ATP-sensitive K+ channels in the absence of SUR1, demonstrating that the primary ATP inhibitory site resides on Kir6.2, while SUR1 is required for sensitivity to sulphonylureas, diazoxide, and activation by Mg-ADP.\",\n      \"method\": \"Heterologous expression of truncated Kir6.2 (Kir6.2ΔC26) in Xenopus oocytes; electrophysiology\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in heterologous system with mutagenesis, foundational study replicated widely\",\n      \"pmids\": [\"9144288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Asparagine 160 (N160) in Kir6.2 lines the pore and contributes to inward rectification by interacting with Mg2+ and spermine; mutation of N160 also alters ATP sensitivity indirectly by changing the open probability of the channel (the energy of the open state), rather than directly affecting ATP binding.\",\n      \"method\": \"Site-directed mutagenesis of N160 in Kir6.2/SUR1 channels expressed in COSm6 cells; electrophysiology\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with quantitative channel kinetics and current-voltage analysis\",\n      \"pmids\": [\"9236207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"PKA phosphorylates Kir6.2 at Ser372 in the C-terminus in intact cells following Gs-coupled receptor stimulation, and this phosphorylation increases K(ATP) channel activity; phosphorylation of SUR1 at Ser1571 by PKA modulates basal channel properties by decreasing burst duration and interburst interval and increasing surface channel number.\",\n      \"method\": \"Mutagenesis of PKA consensus sites in SUR1 and Kir6.2; phosphorylation assays in Xenopus oocyte homogenates and intact cells; electrophysiology\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with phosphorylation assays and functional electrophysiology\",\n      \"pmids\": [\"10469651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The N-terminus of Kir6.2 is involved in coupling sulphonylurea binding to SUR1 to closure of the Kir6.2 pore; deletion of 14 N-terminal amino acids (ΔN14) raises open probability, reduces ATP sensitivity, and abolishes high-affinity tolbutamide block when co-expressed with SUR1, without altering intrinsic Kir6.2 properties when expressed alone.\",\n      \"method\": \"N-terminal deletion and site-directed mutagenesis of Kir6.2; macroscopic current recording in excised patches from Xenopus oocytes\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic deletion mutagenesis with functional electrophysiology\",\n      \"pmids\": [\"10381582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Arginine 50 (R50) in the N-terminus of Kir6.2 is required for normal ATP inhibition; mutation R50S reduces ATP sensitivity ~7-fold; combining N-terminal (R50S) and C-terminal (E179Q) mutations synergistically increases ATP insensitivity, indicating both termini cooperate in ATP-inhibitory gating.\",\n      \"method\": \"Site-directed mutagenesis at R50 and other N-terminal residues of Kir6.2ΔC26; electrophysiology in Xenopus oocytes\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with functional readout, synergy experiment\",\n      \"pmids\": [\"9831713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"N-terminal truncations of Kir6.2 nearly eliminate transitions to interburst closed states, producing extremely high open probability; this reduces apparent ATP sensitivity consistent with the N-terminus controlling interburst gating through a closed state that preferentially binds inhibitory ATP.\",\n      \"method\": \"N-terminal truncation constructs of Kir6.2/SUR1; patch-clamp electrophysiology in heterologous cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with kinetic analysis of channel gating\",\n      \"pmids\": [\"10049691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Kir6.2 physically associates with SUR2A to form the cardiac K(ATP) channel; the proximal C-terminus and M2 transmembrane domain of Kir6.2 are required for this subunit association, while the distal C-terminal 37 amino acids are dispensable.\",\n      \"method\": \"Co-immunoprecipitation of in vitro-translated Kir6.2 and SUR2A; C-terminal deletion mutants\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with deletion mapping in vitro\",\n      \"pmids\": [\"10093054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Kir6.2 protein is localized to the plasma membrane of pancreatic islet alpha-, beta-, and delta-cells as determined by immunofluorescence and in situ hybridization, and is absent from exocrine pancreas.\",\n      \"method\": \"In situ hybridization and immunofluorescence on mouse pancreatic sections; co-staining with insulin, glucagon, and somatostatin antibodies\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization in native tissue with multiple markers\",\n      \"pmids\": [\"9287044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Kir6.2 knockout mice and dominant-negative Kir6.2 transgenic mice demonstrate that K(ATP) channels are the major determinant of beta-cell resting membrane potential; both glucose- and sulphonylurea-induced membrane depolarization, calcium rises, and insulin secretion require closure of K(ATP) channels; K(ATP) channels are also important for beta-cell survival and islet architecture.\",\n      \"method\": \"Kir6.2 knockout and dominant-negative transgenic mice; glucose tolerance tests, calcium imaging, insulin secretion assays\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO and dominant-negative mouse models with multiple orthogonal phenotypic readouts, replicated\",\n      \"pmids\": [\"10868950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Kir6.2 subunit mediates the depression of cardiac excitability and contractility induced by K+ channel openers (pinacidil, P-1075); ventricular cells from Kir6.2 knockout mice lack sarcolemmal K(ATP) channels and do not respond to K+ channel openers, while arterial smooth muscle K(ATP) channels (composed of Kir6.1) are unaffected.\",\n      \"method\": \"Kir6.2 knockout mice; electrophysiology, gene transfer rescue, contractility assays, vascular smooth muscle studies\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with rescue by gene transfer and multiple physiological readouts\",\n      \"pmids\": [\"11282890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Cysteine-scanning mutagenesis identified R50 (N-terminus) and K185 (C-terminus) as residues that interact directly with ATP in the Kir6.2 binding site; K185 interacts primarily with the beta-phosphate and R50 with the gamma-phosphate of ATP.\",\n      \"method\": \"Cysteine-scanning mutagenesis of Kir6.2 combined with charged thiol-modifying reagents (MTSEA/MTSES); electrophysiology; molecular modeling\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cysteine-scanning with chemical modification and ATP analog testing\",\n      \"pmids\": [\"12805206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Kir6.2 mRNA and protein are widely expressed in rat brain neurons (including mitral cells, pontine nucleus, motor nuclei) and in glial cells (astrocytes and oligodendrocytes); immunoelectron microscopy shows Kir6.2 protein localizes to endoplasmic reticulum, Golgi apparatus, and plasma membranes of neurons and glia.\",\n      \"method\": \"Immunohistochemistry, in situ hybridization, double staining with GFAP, immunoelectron microscopy\",\n      \"journal\": \"Brain research. Molecular brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization with multiple methods but functional consequence not directly tested\",\n      \"pmids\": [\"12007828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"R201 and K185 in the C-terminus of Kir6.2 mediate inhibition by adenine nucleotides via electrostatic interactions with phosphate groups; R201 interacts with the alpha-phosphate to stabilize a closed configuration, and K185 interacts with the beta-phosphate to destabilize channel openings in a state-independent fashion.\",\n      \"method\": \"Site-directed mutagenesis at R201, K185, R192, R50; patch-clamp electrophysiology with ATP, ADP, AMP\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with multiple nucleotide analogs and kinetic modeling\",\n      \"pmids\": [\"12524280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Allosteric modulation of Kir6.2 by intracellular H+ and ATP involves His175 (proton sensing) and Lys185 (ATP sensing); mutation of His175 eliminates pH effects on ATP sensitivity, and K185E eliminates the ATP-dependent modulation of pH sensitivity, demonstrating direct interaction between the two regulatory sites.\",\n      \"method\": \"Site-directed mutagenesis (H175, K185) in Kir6.2+/-SUR1; patch-clamp electrophysiology over pH range\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with quantitative functional analysis of allosteric coupling\",\n      \"pmids\": [\"12205184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Kir6.2-knockout mice lack ischemic preconditioning-induced protection of myocardial bioenergetics (ATP turnover, creatine kinase-catalyzed phosphotransfer, and contractile recovery), establishing that Kir6.2-containing K(ATP) channels are integral to preconditioning-induced cardiac energetic protection.\",\n      \"method\": \"Kir6.2 KO mice; 18O-assisted 31P-NMR spectroscopy; ischemia-reperfusion protocol; contractile measurements\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with multimodal energy metabolism assessment\",\n      \"pmids\": [\"12598229\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Heterozygous gain-of-function mutations in Kir6.2 (KCNJ11) cause permanent neonatal diabetes mellitus by reducing channel inhibition by ATP; mutations causing more severe reduction in ATP sensitivity (Q52R, V59G) cause additional neurological features (DEND syndrome), while milder mutations (R201C) cause diabetes alone, correlating disease severity with degree of K(ATP) current increase.\",\n      \"method\": \"Heterologous expression of wild-type and mutant Kir6.2/SUR1 in Xenopus oocytes; electrophysiology; simulated heterozygosity\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — functional reconstitution with multiple disease mutations and quantitative ATP sensitivity measurement\",\n      \"pmids\": [\"15583126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"KCNJ11 mutations causing neonatal diabetes (R201C, R201H, V59M, V59G) increase K(ATP) current in two ways: by decreasing ATP inhibition via Kir6.2 and by enhancing MgATP activation via SUR1 nucleotide-binding domains; the fraction of unblocked current at physiological MgATP correlates with clinical severity.\",\n      \"method\": \"Heterologous expression in Xenopus oocytes; electrophysiology with and without Mg2+; comparison of MgATP vs ATP effects\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — functional reconstitution with multiple mutations and mechanistic dissection of Mg2+-dependent vs independent effects\",\n      \"pmids\": [\"16087682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The I296L mutation at the internal mouth of the Kir6.2 pore (DEND syndrome) reduces ATP sensitivity indirectly by stabilizing the open state, implicating this region in Kir channel gating; the V59G mutation in the slide helix similarly acts by biasing toward open state rather than directly at the ATP binding site.\",\n      \"method\": \"Heterologous expression of mutant Kir6.2/SUR1 in Xenopus oocytes; single-channel and whole-cell electrophysiology; kinetic analysis\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — kinetic analysis combined with molecular modeling and functional reconstitution\",\n      \"pmids\": [\"15864298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The F55L mutation in the Kir6.2 slide helix (congenital hyperinsulinism) reduces the intrinsic open probability of K(ATP) channels ~10-fold without affecting surface expression or nucleotide sensitivity; this low open probability can be reversed by PIP2 or oleoyl-CoA application, identifying reduced phospholipid/acyl-CoA responsiveness as the mechanism.\",\n      \"method\": \"Reconstitution of mutant channels in COS cells; patch-clamp electrophysiology; PIP2/oleoyl-CoA application\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with pharmacological rescue identifying molecular mechanism\",\n      \"pmids\": [\"16332676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Cardiac K(ATP) channels (Kir6.2/SUR2A) are less affected than pancreatic K(ATP) channels (Kir6.2/SUR1) by neonatal diabetes mutations (Q52R, R201H) because SUR2A-containing channels show much less Mg-nucleotide activation enhancement by the mutations; this explains why these gain-of-function mutations produce neurological and pancreatic but not cardiac phenotypes.\",\n      \"method\": \"Comparative electrophysiology of Kir6.2/SUR1 vs Kir6.2/SUR2A heterologously expressed in Xenopus oocytes with and without Mg2+\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct functional comparison with mechanistic explanation for tissue-specific phenotype\",\n      \"pmids\": [\"16339180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"3D structure of the purified Kir6.2-SUR1 K(ATP) channel complex at 18 Å resolution by single-particle electron microscopy reveals four SUR1 subunits embracing a central Kir6.2 tetramer in both transmembrane and cytosolic domains; ATP access cleft identified between adjacent SUR1 subunits; purified channel shows ATPase activity and supports Rb+ fluxes in liposomes.\",\n      \"method\": \"Heterologous expression and purification; single-particle electron microscopy; ATPase assay; liposome Rb+ flux assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural determination with functional validation by multiple methods\",\n      \"pmids\": [\"16308567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The PIP2-binding site on Kir6.2 involves residues in the N-terminus (K39, N41, R54), transmembrane domain (K67), and C-terminus (R176, R177, E179, R301); PIP2 binding increases channel opening and decreases ATP binding/channel inhibition.\",\n      \"method\": \"Homology modeling, ligand docking, and site-directed mutagenesis of Kir6.2; electrophysiology\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — homology modeling validated by systematic mutagenesis with functional readout\",\n      \"pmids\": [\"17673911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"A conserved alpha-helical region (residues ~306-315) in the Kir6.2 C-terminus, particularly E308, I309, W311, and F315, forms a critical phospholipid-interaction domain; GFP-tagged Kir6.2 C-terminus associates with isolated membranes in a PIP2-dependent manner that is reduced by m1 receptor-mediated phospholipid depletion.\",\n      \"method\": \"GFP-fusion membrane association assay; systematic mutagenesis of C-terminal helix; muscarinic receptor-mediated PIP2 depletion\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — membrane association assay combined with systematic mutagenesis\",\n      \"pmids\": [\"12034765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SUR1 residue E203 and Kir6.2 residue Q52 are in close proximity and interact to modulate ATP sensitivity; E203K/Q52E double mutant channels show ~100-fold higher ATP sensitivity; cross-linking of E203C/Q52C locks the channel in a closed state reversible by reducing agents, demonstrating this interaction dynamically regulates channel gating.\",\n      \"method\": \"Charge-swap mutagenesis; cysteine cross-linking with oxidizing/reducing agents; electrophysiology in Xenopus oocytes\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cross-linking mutagenesis with functional validation demonstrating direct subunit interaction\",\n      \"pmids\": [\"22802363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"High-affinity repaglinide binding (~150-fold increase vs SUR1 alone) requires both Kir6.2 co-expression with SUR1 and an intact Kir6.2 N-terminus; deletion of Kir6.2 N-terminal 14 residues abolishes high-affinity repaglinide binding, indicating that Kir6.2 causes a conformational change in SUR1 or contributes directly to the repaglinide binding site.\",\n      \"method\": \"Radioligand binding ([3H]-glibenclamide) with co-expressed Kir6.2/SUR1 in membranes; N-terminal deletion mutants; whole-cell patch-clamp\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — binding assay combined with mutagenesis and functional electrophysiology\",\n      \"pmids\": [\"15678092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Progressive N-terminal truncation of Kir6.2 impairs transduction of sulphonylurea (glibenclamide, repaglinide) binding into channel closure and accelerates glibenclamide dissociation, establishing that the Kir6.2 N-terminus is required for coupling drug binding at SUR1 to pore closure.\",\n      \"method\": \"Progressive N-terminal truncation of Kir6.2 (up to 20 amino acids); equilibrium [3H]-glibenclamide binding; inside-out patch-clamp in HEK cells\",\n      \"journal\": \"Naunyn-Schmiedeberg's archives of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic truncation with binding kinetics and electrophysiology\",\n      \"pmids\": [\"22083559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"βIV-spectrin directly associates with Kir6.2 in pancreatic islets and recruits CaMKII; CaMKII directly phosphorylates Kir6.2 at Thr224, and this phosphorylation inhibits K(ATP) channel function; βIV-spectrin mutant mice lacking CaMKII-binding motifs show aberrant Kir6.2 phosphorylation and altered insulin regulation.\",\n      \"method\": \"Co-immunoprecipitation; in vitro phosphorylation assay; mutagenesis of T224; electrophysiology; βIV-spectrin mutant mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, in vitro kinase assay with site mutagenesis, and in vivo mouse model converging on same finding\",\n      \"pmids\": [\"24101510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Kir6.2 is palmitoylated at Cys166; palmitoylation promotes channel opening by increasing open time and enhancing PIP2 sensitivity without affecting surface expression; mutagenesis of C166 prevents palmitoylation effects; clinical KCNJ11 variants affecting C166 show gain-of-function consistent with enhanced PIP2 interaction.\",\n      \"method\": \"Acyl-biotin exchange assay; patch-clamp electrophysiology in transfected cells, INS-1 cells, and cardiac myocytes; C166 mutagenesis; molecular modeling; palmitoylation inhibition/palmitate preincubation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical palmitoylation detection combined with mutagenesis, functional assay in multiple cell types, and structural modeling\",\n      \"pmids\": [\"32332165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Targeted expression of Kir6.2 in mitochondria of HEK293 and HL-1 cells increases mitochondrial K+ influx, substantially improves cell viability after hypoxic stress, and attenuates mitochondrial Ca2+ accumulation; an inactive Kir6.2 mutant abolishes these protective effects.\",\n      \"method\": \"Mitochondrial-targeted Kir6.2 expression via pCMV/mito/GFP vector; PBFI-AM K+ fluorescence; LDH release assay; rhod-2 mitochondrial Ca2+ measurement; inactive mutant control\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct organelle-targeted expression with inactive mutant control and multiple readouts\",\n      \"pmids\": [\"16959852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Kir6.2 gene expression in intestinal progenitor cells is regulated by transcription factors Foxa2 (via a -1364/-1210 element) and Sp1/Sp3 (via a -1035/-939 element) in the Kir6.2 promoter; Isl-1 attenuates Foxa2 overexpression to enable Kir6.2 expression; knockdown of Isl-1 in beta-cells reduces Kir6.2 protein.\",\n      \"method\": \"Luciferase reporter assay; EMSA; Pdx-1/Isl-1 overexpression; Isl-1 siRNA knockdown in RIN-5F cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter dissection with EMSA and functional reporter, validated by siRNA knockdown\",\n      \"pmids\": [\"15528203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Memantine blocks Kir6.2-containing K(ATP) channels (inhibits Kir6.2 expressed in neuro2A cells, elevating intracellular Ca2+); Kir6.2 knockout mice exhibit severe memory deficits and impaired hippocampal LTP that cannot be rescued by memantine, establishing Kir6.2 as a target for memantine-mediated memory enhancement.\",\n      \"method\": \"Kir6.2 overexpression in neuro2A cells with Ca2+ measurement; Kir6.2 KO mice; hippocampal LTP recording; CaMKII activity assay; pinacidil rescue experiment\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with LTP and behavioral phenotype combined with pharmacological intervention and Ca2+ measurement\",\n      \"pmids\": [\"27777420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Gene delivery of Kir6.2/SUR2A into cells lacking native K(ATP) channels confers resistance to metabolic (hypoxia-reoxygenation) stress by preventing intracellular Ca2+ loading; this effect is blocked by 5-hydroxydecanoate and requires the K+ channel activator pinacidil, establishing a direct causal link between Kir6.2/SUR2A channel activation and Ca2+ homeostasis under stress.\",\n      \"method\": \"Gene transfer of Kir6.2/SUR2A into somatic cells; fluorescent Ca2+ measurement; pharmacological inhibition with 5-HD\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function gene transfer with pharmacological validation\",\n      \"pmids\": [\"10224235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NFκB signaling elevates KCNJ11 expression in hepatocellular carcinoma; KCNJ11 protein interacts with lactate dehydrogenase A (LDHA) and enhances its enzymatic activity, promoting tumor cell proliferation, reducing apoptosis, and increasing invasion; pharmacological inhibition of LDHA compromises these KCNJ11-dependent oncogenic functions.\",\n      \"method\": \"NFκB inhibition; KCNJ11 knockdown; co-immunoprecipitation of KCNJ11-LDHA complex; LDHA enzymatic activity assay; cell proliferation/apoptosis/invasion assays; pharmacological LDHA inhibition\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP identifying interaction combined with enzymatic assay and functional rescue\",\n      \"pmids\": [\"29108994\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KCNJ11 (Kir6.2) forms the pore-forming subunit of the octameric K(ATP) channel by assembling as a tetramer with four SUR subunits (SUR1 in pancreatic beta-cells, SUR2A in heart); ATP inhibits channel activity by binding directly to Kir6.2 at a site involving N-terminal residues (R50, I49) and C-terminal residues (K185, R201, E179), while MgADP and sulphonylureas act via SUR; channel gating is further modulated by PIP2 binding to a conserved site on Kir6.2, palmitoylation at Cys166, PKA phosphorylation at Ser372, CaMKII phosphorylation at Thr224 (mediated by a βIV-spectrin scaffold), and intracellular pH; in pancreatic beta-cells, channel closure links glucose metabolism to insulin secretion, and gain-of-function mutations reduce ATP sensitivity causing neonatal diabetes (with neurological complications when the open-state stabilization is particularly severe), while loss-of-function mutations cause congenital hyperinsulinism.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"KCNJ11 (Kir6.2) encodes the pore-forming subunit of ATP-sensitive potassium (K_ATP) channels, coupling cellular metabolic status to membrane excitability across pancreatic islet cells, cardiomyocytes, and neurons. Kir6.2 assembles as a tetramer with four sulfonylurea receptor subunits (SUR1 or SUR2A) to form an octameric channel complex; ATP directly inhibits the channel by binding a site composed of N-terminal (R50) and C-terminal (K185, R201) residues on Kir6.2, while MgADP activation and sulfonylurea-mediated closure are transduced through SUR, with the Kir6.2 N-terminus required for coupling drug binding to pore gating [PMID:9144288, PMID:12805206, PMID:12524280, PMID:22083559]. Channel open probability is further tuned by PIP2 binding to a distributed site spanning both termini and the transmembrane domain, by palmitoylation at Cys166 that enhances PIP2 sensitivity, by PKA phosphorylation at Ser372, by CaMKII phosphorylation at Thr224 scaffolded by βIV-spectrin, and by intracellular pH sensed through His175 [PMID:17673911, PMID:32332165, PMID:10469651, PMID:24101510, PMID:12205184]. Gain-of-function mutations that reduce ATP sensitivity cause permanent neonatal diabetes—with severity ranging from isolated diabetes (R201C/H) to diabetes with developmental delay, epilepsy, and neonatal diabetes (DEND syndrome; Q52R, V59G, I296L)—while loss-of-function mutations (e.g., F55L) cause congenital hyperinsulinism; in the heart, Kir6.2-containing channels mediate ischemic preconditioning and stress-induced cardioprotection [PMID:15583126, PMID:16332676, PMID:12598229].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Whether the ATP-inhibitory site resides on the pore subunit or the accessory SUR was unknown; truncation of the Kir6.2 C-terminus produced functional ATP-sensitive channels without SUR1, establishing that Kir6.2 itself harbors the primary ATP gate.\",\n      \"evidence\": \"Expression of Kir6.2ΔC26 in Xenopus oocytes; electrophysiology\",\n      \"pmids\": [\"9144288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact residues forming the ATP binding pocket not yet identified\", \"SUR contribution to ATP sensitivity modulation not fully dissected\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"The identity of pore-lining residues and their influence on gating was unresolved; N160 was shown to line the pore and mediate inward rectification, and its mutation altered ATP sensitivity indirectly by changing open probability rather than ATP binding affinity.\",\n      \"evidence\": \"Site-directed mutagenesis of N160 in Kir6.2/SUR1; electrophysiology in COSm6 cells\",\n      \"pmids\": [\"9236207\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full pore structure unknown at this resolution\", \"How open probability modulates apparent ATP sensitivity only conceptually understood\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"The contribution of Kir6.2 structural domains to ATP binding and gating was mapped: the N-terminus controls interburst gating and couples SUR1 drug binding to pore closure, while R50 in the N-terminus cooperates with C-terminal E179 for ATP inhibition.\",\n      \"evidence\": \"Systematic N-terminal deletions, R50 mutagenesis, and synergy analysis in Xenopus oocytes; single-channel kinetics\",\n      \"pmids\": [\"9831713\", \"10381582\", \"10049691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct contact between R50 and ATP not yet proven by accessibility methods\", \"Mechanism coupling N-terminal conformational change to SUR1 drug binding unresolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"How the channel assembles with different SUR isoforms was unclear; the Kir6.2 proximal C-terminus and M2 domain were shown to mediate physical association with SUR2A, defining the cardiac channel assembly interface.\",\n      \"evidence\": \"Co-immunoprecipitation of in vitro-translated Kir6.2 and SUR2A; C-terminal deletion mutants\",\n      \"pmids\": [\"10093054\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vitro translation system may not recapitulate native assembly\", \"No reciprocal mapping on SUR2A side\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Whether Kir6.2 channel activity is regulated by second-messenger cascades was unknown; PKA was shown to phosphorylate Kir6.2 at Ser372 downstream of Gs-coupled receptors, increasing channel activity.\",\n      \"evidence\": \"Mutagenesis of PKA sites; phosphorylation assays in oocytes and intact cells; electrophysiology\",\n      \"pmids\": [\"10469651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological context of PKA-mediated regulation in beta-cell insulin secretion not directly tested\", \"Whether other kinases also target Kir6.2 unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"The in vivo role of Kir6.2 in beta-cell physiology was unproven; Kir6.2 knockout and dominant-negative transgenic mice demonstrated that K_ATP channels set beta-cell resting potential and are required for glucose- and sulfonylurea-stimulated insulin secretion.\",\n      \"evidence\": \"Kir6.2 KO and dominant-negative transgenic mice; glucose tolerance, calcium imaging, insulin secretion\",\n      \"pmids\": [\"10868950\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Compensatory changes in KO mice not fully characterized\", \"Role in alpha- and delta-cell physiology not dissected\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Whether Kir6.2 is the essential pore subunit of cardiac sarcolemmal K_ATP channels was uncertain; Kir6.2 KO mice lacked cardiac K_ATP currents and K+ channel opener responses, while vascular Kir6.1-based channels were unaffected, establishing tissue-specific subunit usage.\",\n      \"evidence\": \"Kir6.2 KO mice; electrophysiology, gene transfer rescue, contractility and vascular studies\",\n      \"pmids\": [\"11282890\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Kir6.2 also contributes to vascular or mitochondrial channels in vivo not resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"PIP2 regulation of Kir6.2 was known but the structural basis was unclear; a conserved C-terminal alpha-helix (residues 306–315) was identified as a phospholipid-interaction domain, and allosteric coupling between pH sensing (His175) and ATP inhibition (Lys185) was demonstrated.\",\n      \"evidence\": \"GFP-fusion membrane association assay with mutagenesis; pH-titration electrophysiology with H175/K185 mutants\",\n      \"pmids\": [\"12034765\", \"12205184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full PIP2 binding site not yet mapped\", \"Whether pH regulation is physiologically relevant in beta-cells not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"The identities of residues directly contacting ATP were unknown; cysteine-scanning and mutagenesis established that R50 contacts the γ-phosphate, K185 the β-phosphate, and R201 the α-phosphate of ATP, defining the complete inhibitory binding site.\",\n      \"evidence\": \"Cysteine-scanning mutagenesis with charged thiol reagents; electrophysiology with ATP analogs; site-directed mutagenesis with AMP/ADP/ATP\",\n      \"pmids\": [\"12805206\", \"12524280\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No atomic-resolution structure of the ATP binding pocket\", \"Conformational changes upon ATP binding not directly visualized\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"The role of cardiac K_ATP channels in ischemic preconditioning was debated; Kir6.2 KO mice failed to develop preconditioning-induced bioenergetic protection, establishing Kir6.2-containing channels as essential mediators.\",\n      \"evidence\": \"Kir6.2 KO mice; 18O-assisted 31P-NMR spectroscopy; ischemia-reperfusion with contractile measurements\",\n      \"pmids\": [\"12598229\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether sarcolemmal or mitochondrial Kir6.2 channels mediate preconditioning not distinguished\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The genetic basis of permanent neonatal diabetes was being elucidated; heterozygous gain-of-function KCNJ11 mutations were shown to cause neonatal diabetes by reducing ATP inhibition, with mutation severity correlating to clinical phenotype—mild mutations causing diabetes alone and severe mutations causing DEND syndrome.\",\n      \"evidence\": \"Heterologous expression of disease mutations in Xenopus oocytes; electrophysiology with simulated heterozygosity\",\n      \"pmids\": [\"15583126\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why some mutations cause transient vs permanent neonatal diabetes unknown\", \"In vivo confirmation in mouse models not yet done\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Multiple mechanistic advances converged: disease mutations were shown to act both by reducing direct ATP block on Kir6.2 and by enhancing MgATP activation via SUR1; tissue specificity was explained by differential SUR2A vs SUR1 responses; loss-of-function (hyperinsulinism) mutations were shown to reduce PIP2 sensitivity; the first 3D structure of the octameric complex was obtained at 18 Å; and the Kir6.2 N-terminus was required for high-affinity drug binding.\",\n      \"evidence\": \"Comparative electrophysiology of SUR1 vs SUR2A channels; F55L reconstitution with PIP2 rescue; single-particle EM at 18 Å with ATPase and Rb+ flux validation; radioligand binding with N-terminal deletions\",\n      \"pmids\": [\"16087682\", \"16339180\", \"16332676\", \"16308567\", \"15678092\", \"15864298\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution structure needed to resolve ATP and PIP2 binding sites\", \"How MgATP activation through SUR1 NBDs is mechanistically coupled to Kir6.2 gating unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The full PIP2 binding site was mapped across both termini and the transmembrane domain, revealing a distributed interaction surface involving K39, R54, K67, R176, R177, and R301.\",\n      \"evidence\": \"Homology modeling with ligand docking validated by systematic mutagenesis and electrophysiology\",\n      \"pmids\": [\"17673911\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No direct structural visualization of PIP2 bound to Kir6.2\", \"Relative contribution of each residue to PIP2 affinity not quantified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"How SUR1 communicates with the Kir6.2 pore was structurally unresolved; charge-swap and cysteine cross-linking between SUR1-E203 and Kir6.2-Q52 demonstrated a direct physical interface that dynamically regulates ATP-dependent gating.\",\n      \"evidence\": \"Charge-swap mutagenesis and oxidative cross-linking in Xenopus oocytes; electrophysiology\",\n      \"pmids\": [\"22802363\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether additional SUR1–Kir6.2 contact points exist beyond E203–Q52 not known\", \"Structural basis at atomic resolution not available\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Whether scaffold proteins recruit kinases to Kir6.2 was unknown; βIV-spectrin was shown to associate with Kir6.2 and recruit CaMKII, which phosphorylates Thr224 to inhibit channel activity, providing a new regulatory mechanism in islets.\",\n      \"evidence\": \"Co-IP; in vitro kinase assay; T224 mutagenesis; electrophysiology; βIV-spectrin mutant mice\",\n      \"pmids\": [\"24101510\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CaMKII-mediated phosphorylation regulates Kir6.2 in neurons or heart not tested\", \"Signaling cascades upstream of CaMKII at the channel not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Post-translational lipid modification of Kir6.2 was unexplored; palmitoylation at Cys166 was discovered to promote channel opening by enhancing PIP2 sensitivity, adding a lipid-based regulatory layer.\",\n      \"evidence\": \"Acyl-biotin exchange; patch-clamp in transfected cells, INS-1 cells, and cardiomyocytes; C166 mutagenesis; molecular modeling\",\n      \"pmids\": [\"32332165\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which palmitoyl transferase modifies Kir6.2 unknown\", \"Whether palmitoylation is dynamically regulated by metabolic state not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include: the high-resolution structural basis of ATP/PIP2 binding and gating transitions; how palmitoylation is enzymatically regulated; the precise mechanism by which SUR nucleotide-binding domain activation is transduced to Kir6.2 pore opening; and whether Kir6.2 functions in mitochondrial membranes in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution cryo-EM structure with bound ATP and PIP2 simultaneously resolved in the timeline\", \"Enzymatic palmitoylation/depalmitoylation machinery not identified\", \"In vivo evidence for mitochondrial Kir6.2 remains indirect\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 8, 9]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [21, 22, 27]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [7, 8, 9, 11]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 1, 8, 9]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 8, 26]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [30]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [15, 16, 18]}\n    ],\n    \"complexes\": [\n      \"K_ATP channel (Kir6.2/SUR1)\",\n      \"K_ATP channel (Kir6.2/SUR2A)\"\n    ],\n    \"partners\": [\n      \"ABCC8\",\n      \"ABCC9\",\n      \"SPTBN4\",\n      \"CAMK2A\",\n      \"LDHA\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}